Change in Management

Ceo ResignedCeo Appointed ExternalKmp ResignedManagement Changes View source PDF Explain this filing

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-9.4%Reaction day

₹790.00

prior close

₹730.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-10.1% vs market

Pharmaceuticals peers, median of 162sector+0.0%-9.4% vs sector

On the reaction day the stock moved 10.1 pts less than Nifty Microcap 250 and 9.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.9

10m

-1.9

15m

-2.3

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-9.4+0.7-10.1+0.0-9.4

Next day

-10.5+0.9-11.4+0.5-11.0

-8.6+0.6-9.2+0.0-8.6

-10.1-0.8-9.3-0.6-9.5

-9.2-0.4-8.9-0.1-9.2

-10.4+0.2-10.6+1.0-11.3

-10.6+1.4-12.1+0.8-11.5

15d

-8.8+4.2-13.0+1.1-9.9

-8.3+6.3-14.6+2.6-11.0

-11.2+11.3-22.5+6.8-18.0

+1.7+14.0-12.3+9.2-7.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Albert David Ltd appointed Mr. Amit Mahla as CEO effective May 12, 2026. The appointment follows the resignation of Mr. Umesh Manohar Kunte from Managing Director & CEO post, effective December 18, 2025 (disclosed now). Mr. Mahla brings 28+ years of pharma experience from companies including JB Pharma, Sun Pharma, and Cipla. FY26 full-year results show revenue of Rs. 33,360 Lacs (vs Rs. 34,577 Lacs in FY25) and a net loss of Rs. 149 Lacs versus profit of Rs. 1,720 Lacs in prior year. The Q4 standalone quarter also recorded a loss of Rs. 2,143 Lacs. The board recommended a final dividend of Rs. 5 per share (50%), subject to shareholder approval at the August 6, 2026 AGM. Statutory auditors L.B. Jha & Co. issued an unmodified opinion.

Likely market impact

The new CEO appointment from outside the company signals a potential strategic reset, though the significant FY26 loss and revenue decline may weigh on investor sentiment near-term. The dividend offer provides some investor relief.